TECH vs UHS — Key Metrics

Metric TECH (BIO-TECHNE CORP) UHS (UNIVERSAL HEALTH SERVICES INC)
Price72.75186.07
Market Cap11.43 Billion10.73 Billion
P/E (TTM)66.147.71
P/B (Quarterly)5.2841.484
P/S (TTM)9.30.58
Net Profit Margin (TTM)14.08.0
Gross Margin (TTM)65.843.7
ROE (TTM)8.219.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

BIO-TECHNE CORP
vs
 
UNIVERSAL HEALTH SERVICES INC
 
BIO-TECHNE CORP
vs
 
UNIVERSAL HEALTH SERVICES INC
Performance Comparison
AI Model Recommendation
TECH · BIO-TECHNE CORP

Underperform

-43
UnderperformOutperform
UHS · UNIVERSAL HEALTH SERVICES INC

Outperform

10
UnderperformOutperform
Recommendation Summary

Stock TECH is projected to underperform the market, stock UHS is projected to outperform the market. Upfront Recommendation: UHS.

Financial Metrics
Prices delayed ~15 min
TECH Metrics UHS
$72.75 Price $186.07
— Market Capitalization —
66.14 Price to Earnings Ratio 7.71
9.3 Price to Sales 0.58
37.08 Price to FCF Ratio 9.81
14.15 Price to Gross Profit 1.34
13.86 Price to Current Assets 2.91

TECH vs UHS at a glance

Bio-techne Corp (TECH) and Universal Health Services INC (UHS) are both in the Healthcare sector. They are similar in size: $11.4 billion and $10.7 billion in market value.

On trailing-twelve-month figures, TECH trades at 66.1 times trailing earnings and UHS at 7.7; net profit margins are 14.0% and 8.0%.

The Upfront Investment model currently rates TECH Underperform and UHS Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.